3.20
price up icon3.23%   0.10
after-market 시간 외 거래: 3.13 -0.07 -2.19%
loading
전일 마감가:
$3.10
열려 있는:
$3.2
하루 거래량:
34,087
Relative Volume:
28.44
시가총액:
$32.45M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
Value
$3.10
$3.27
1주일 범위
Value
$3.10
$3.32
52주 변동 폭
Value
$3.10
$3.32

Grace Therapeutics Inc Stock (GRCE) Company Profile

Name
명칭
Grace Therapeutics Inc
Name
전화
-
Name
주소
-
Name
직원
4
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
GRCE's Discussions on Twitter

Grace Therapeutics Inc 주식(GRCE)의 최신 뉴스

pulisher
Oct 31, 2024

Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View - MSN

Oct 31, 2024
pulisher
Oct 30, 2024

Biopharma Co. Can't Knock Ex-CFO's Bias Suit Out Of Court - Law360

Oct 30, 2024
pulisher
Oct 30, 2024

Corcept Therapeutics Announces Third Quarter Financial Results, Positive Results From Phase 3 GRADIENT Trial in Patients With Cushing’s Syndrome and Provides Corporate Update - StockTitan

Oct 30, 2024
pulisher
Oct 30, 2024

GRCE (Grace Therapeutics) Cash Flow from Financing : $7.36 Mil (TTM As of Jun. 2024) - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Acasti Pharma Inc. Announces Poster Detailing Its GTX-104 STRIVE-ON Trial - Marketscreener.com

Oct 30, 2024
pulisher
Oct 30, 2024

Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024 - The Manila Times

Oct 30, 2024
pulisher
Oct 29, 2024

OTC Markets Hosts Virtual Investor Presentation with Prashant Kohli, CEO of Grace Therapeutics (Acasti Pharma), with John Vandermosten, Senior Analyst at Zacks SCR - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Acasti Pharma Inc. Announces Resignation of Jean-Marie Canan from Board of Directors and Member of Audit Committee and Governance and Human Resources Committee - Marketscreener.com

Oct 29, 2024
pulisher
Oct 28, 2024

Grace Therapeutics announces name change and new ticker - Investing.com India

Oct 28, 2024
pulisher
Oct 27, 2024

KB Financial Group (NYSE:KB) Sets New 1-Year High – Should You Buy? - Defense World

Oct 27, 2024
pulisher
Oct 25, 2024

Acasti Pharma transitions to Grace Therapeutics, trading as GRCE - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

ACSTAcasti Pharma, Inc. Latest Stock News & Market Updates - StockTitan

Oct 25, 2024
pulisher
Oct 25, 2024

Hurco Poised to Pioneer the Future of Manufacturing - The Manila Times

Oct 25, 2024
pulisher
Oct 25, 2024

Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - GlobeNewswire

Oct 25, 2024
pulisher
Sep 30, 2024

Student loan grace period expires: What borrowers need to know - Yahoo Finance

Sep 30, 2024
pulisher
Sep 25, 2024

Acasti Pharma Inc. Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104 - Marketscreener.com

Sep 25, 2024
pulisher
Sep 13, 2024

Seeking Online Therapy as a Christian? Look No Further Than These 6 Companies - Verywell Mind

Sep 13, 2024
pulisher
May 17, 2024

H. Jack West, MD - Oncology News Central

May 17, 2024
pulisher
Apr 24, 2024

Relacorilant shows significant benefits in Cushing’s patients in trial - Cushing's Disease News

Apr 24, 2024
pulisher
Mar 25, 2024

Andelyn Biosciences Partners With Grace Science To Advance GS-100 - Contract Pharma

Mar 25, 2024
pulisher
Mar 19, 2024

This biotech incubator has built 100+ companies by asking, What if . . . ? - Fast Company

Mar 19, 2024
pulisher
Feb 12, 2024

Acasti: Fiscal Q3 Earnings Snapshot - Marketscreener.com

Feb 12, 2024
pulisher
Dec 27, 2023

AstraZeneca pays $1B to take the wheel of Gracell’s CAR-T ‘fast car’ - Fierce Biotech

Dec 27, 2023
pulisher
Dec 26, 2023

AstraZeneca to buy China's Gracell Biotechnologies in $1.2 billion deal - Reuters.com

Dec 26, 2023
pulisher
Nov 08, 2023

Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq's Bid Price Rule - Yahoo Finance

Nov 08, 2023
pulisher
Sep 25, 2023

Halle Berry’s number one tip for going number two - Fast Company

Sep 25, 2023
pulisher
Aug 08, 2023

Chinese CAR T-maker Gracell raises $150M in private financing - BioWorld Online

Aug 08, 2023
pulisher
Aug 04, 2023

Trial data for Cushing's treatments relacorilant, Korlym due next year - Cushing's Disease News

Aug 04, 2023
pulisher
Jul 28, 2023

Biogen to Acquire Reata Pharmaceuticals - Vinson & Elkins LLP

Jul 28, 2023
pulisher
May 22, 2023

Pear Therapeutics was sold for parts to four companies for about $6M last week. - Axios

May 22, 2023
pulisher
May 09, 2023

NJ Bioscience Center-Incubator - NJEDA (.gov)

May 09, 2023
pulisher
May 05, 2023

Corcept planning to seek relacorilant approval for Cushing’s in 2024 - Cushing's Disease News

May 05, 2023
pulisher
Apr 05, 2023

Acasti Pharma Inc. to Proceed with Phase 3 Clinical Safety Study for GTX-104 - Marketscreener.com

Apr 05, 2023
pulisher
Mar 03, 2023

GRACE Phase 3 trial of relacorilant nears complete enrollment - Cushing's Disease News

Mar 03, 2023
pulisher
Jan 02, 2023

Early‐onset reduced bone mineral density in patients with pyruvate kinase deficiency - Wiley Online Library

Jan 02, 2023
pulisher
Nov 14, 2022

Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022 - Quantisnow

Nov 14, 2022
pulisher
Oct 26, 2022

Nonprofit FAST Has Cure for Angelman Syndrome in Its Sights |... - Angelman Syndrome News

Oct 26, 2022
pulisher
Jul 13, 2022

Tiny arms, big relief: Finally a COVID-19 vaccine for Mattie Grace - Walgreens Boots Alliance

Jul 13, 2022
pulisher
May 27, 2022

Pfizer and Moderna rapidly falling out of favor as Americans' favorite brands: report - FiercePharma

May 27, 2022
pulisher
Feb 18, 2022

Corcept Will Seek FDA Approval of Relacorilant in 2023 - Cushing's Disease News

Feb 18, 2022
pulisher
Jan 25, 2022

Alira Health Expands its Digital Health Portfolio with the Acquisition of Self Care Catalysts - Business Wire

Jan 25, 2022
pulisher
Oct 08, 2021

Grace Simoni Obituary (19502015)Lubbock, TXLubbock Avalanche-Journal - Legacy.com

Oct 08, 2021
pulisher
Sep 16, 2021

The Champion for Rare Disease Cures - proto.life

Sep 16, 2021
pulisher
Jun 01, 2021

Parexel Appoints Chief Patient Officer - Contract Pharma

Jun 01, 2021
pulisher
May 21, 2021

How to convert your intellectual property IP - EisnerAmper

May 21, 2021
pulisher
May 19, 2021

Biotech Penny Stocks Pushing Up During The Crypto Crash, One Up 25% - Penny Stocks

May 19, 2021
pulisher
May 11, 2021

Acasti Pharma to Acquire Indian Origin Emerging Biopharmaceutical Grace Therapeutics - News18

May 11, 2021
pulisher
May 09, 2021

US-based Acasti Pharma to buy Indian origin pharma firm Grace - The Economic Times

May 09, 2021
pulisher
Jul 23, 2019

Nature’s Grace and JC Pharma Inc Release CannatolRx Nasal Rescue Spray - mg Magazine

Jul 23, 2019
pulisher
Jul 04, 2018

​Up Cannabis Reveals Strains Named After Tragically Hip Songs - Exclaim!

Jul 04, 2018

Grace Therapeutics Inc (GRCE) 재무 분석

Grace Therapeutics Inc (GRCE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.32
price down icon 1.11%
$74.12
price up icon 0.26%
$373.97
price up icon 3.48%
$54.36
price down icon 0.66%
$202.64
price down icon 1.63%
$113.10
price down icon 0.74%
자본화:     |  볼륨(24시간):